Assistant Professor, Emergency Medicine, Perelman School of Medicine

Rheumatology

Dr. David A. Allan, MD


David Allan is an expert in the field of Rheumatology. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACR)". Dr. David A. Allan is also a published physician. He has 2 publication published. The most recent publication is: Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. He accepts all Medicare patients.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Hospital


Drug Facts


NPI NUMBER   1376518233
NPPES Provider LastName   ALLAN
NPPES Provider FirstName   DAVID
NPPES Provider ZIPCode   191042692
NPPES Provider State   PA
Specialty Description   Rheumatology
Total Claim Count   336.0
Distinct Opioid Count   1.0
Opioid Claim Count   12.0
Percent Opioid Claims   3.57

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1376518233
Last Name Of The Provider ALLAN
First Name Of The Provider DAVID
View All

Similar Doctors


Dr. Helene J. Casselli, MD
This Doctor is OpenDoctor Recommended.
Dr. Francis C. Luk, MD
Dr. John A. Getsy, DO
Dr. Rebecca Sharim, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. King S. Goh, MD
Dr. Maryah Mansoor, MD
Dr. Lan X. Chen, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Philip L. Cohen, MD
This Doctor is OpenDoctor Recommended.
Dr. Folashade O. Alade, MD
Dr. Augusto M. Quilon III, MD
This Doctor is OpenDoctor Recommended.
Dr. Jayne E. Littlejohn, MD
This Doctor is OpenDoctor Recommended.
Dr. Dana B. Jacobs-Kosmin, MD
Dr. Geo S. Derimanov, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Humaira N. Adenwalla, MD
This Doctor is OpenDoctor Recommended.
Dr. Belinda K. Birnbaum, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications


Doctor Directory | TOS | twitter | FB | Angel | blog